Latest Price Targets from the World's Best Analysts & Research Firms
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Communication Services
Consumer Discretionary
Consumer Staples
Energy
Financials
Healthcare
Industrials
Materials
Real Estate
Technology
Utilities
Communication Services
Advertising Agencies
Broadcasting
Electronic Gaming & Multimedia
Entertainment
Internet Content & Information
Publishing
Telecom Services
Consumer Discretionary
Apparel Manufacturing
Apparel Retail
Auto Manufacturers
Auto Parts
Auto & Truck Dealerships
Department Stores
Footwear & Accessories
Furnishings, Fixtures & Appliances
Gambling
Home Improvement Retail
Internet Retail
Leisure
Lodging
Luxury Goods
Packaging & Containers
Personal Services
Recreational Vehicles
Residential Construction
Resorts & Casinos
Restaurants
Specialty Retail
Textile Manufacturing
Travel Services
Consumer Staples
Beverages - Brewers
Beverages - Non-Alcoholic
Beverages - Wineries & Distilleries
Confectioners
Discount Stores
Education & Training Services
Farm Products
Food Distribution
Grocery Stores
Household & Personal Products
Packaged Foods
Tobacco
Energy
Oil & Gas Drilling
Oil & Gas Equipment & Services
Oil & Gas Exploration & Production
Oil & Gas Integrated
Oil & Gas Midstream
Oil & Gas Refining & Marketing
Thermal Coal
Uranium
Financials
Asset Management
Banks - Diversified
Banks - Regional
Capital Markets
Credit Services
Diversified Insurance
Financial Conglomerates
Financial Data & Stock Exchanges
Insurance Brokers
Life Insurance
Mortgage Finance
Property & Casualty Insurance
Reinsurance
Shell Companies
Specialty - Insurance
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Healthcare Plans
Health Information Services
Medical Care Facilities
Medical Devices
Medical Distribution
Medical Instruments & Supplies
Pharmaceutical Retailers
Industrials
Aerospace & Defense
Airlines
Airports & Air Services
Building Products & Equipment
Business Equipment & Supplies
Conglomerates
Consulting Services
Electrical Equipment & Parts
Engineering & Construction
Farm & Heavy Construction Machinery
Industrial Distribution
Infrastructure Operations
Integrated Freight & Logistics
Marine Shipping
Metal Fabrication
Pollution & Treatment Controls
Railroads
Rental & Leasing Services
Security & Protection Services
Specialty Business Services
Specialty Industrial Machinery
Staffing & Employment Services
Tools & Accessories
Trucking
Waste Management
Materials
Agricultural Inputs
Aluminum
Building Materials
Chemicals
Coking Coal
Copper
Gold
Lumber & Wood Production
Other Industrial Metals & Mining
Other Precious Metals & Mining
Paper & Paper Products
Silver
Specialty Chemicals
Steel
Real Estate
Diversified REIT
Healthcare Facilities REIT
Hotel & Motel REIT
Industrial REIT
Mortgage REIT
Office REIT
Real Estate Development
Real Estate Diversified
Real Estate Services
Residential REIT
Retail REIT
Specialty REIT
Technology
Communication Equipment
Computer Hardware
Consumer Electronics
Electronic Components
Electronics & Computer Distribution
Information Technology Services
Scientific & Technical Instruments
Semiconductor Equipment & Materials
Semiconductors
Software - Application
Software - Infrastructure
Solar
Utilities
Diversified Utilities
Electric Utilities
Gas Utilities
Independent Power Producers
Renewable Electricity
Water Utilities
Positive
Neutral
Negative
7 Days
1 Month
3 Months
6 Months
# | Analyst & Firm | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
11626 |
K
11626
Keybanc
Sophie Karp
|
Enphase Energy
ENPH
$4.91B
| $37.53 | $31 |
17%
downside
| Underweight |
17 Jun ‘25
2 months ago |
|
11627 |
B
11627
Barclays
Tom O'Malley
|
NVIDIA
NVDA
$4.35T
| $178.75 | $200 |
12%
upside
| Overweight |
17 Jun ‘25
2 months ago |
|
11628 |
JR
11628
Johnson Rice
Martin Malloy
|
VG
Venture Global, Inc.
VG
$32.7B
| $13.48 | $20 |
48%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
11629 |
JM
11629
JP Morgan
James Gordon
|
Grifois
GRFS
$6.76B
| $9.93 | $10.30 |
4%
upside
| Neutral |
17 Jun ‘25
2 months ago |
|
11630 |
JM
11630
JP Morgan
Anthony Paolone
|
AvalonBay Communities
AVB
$27.6B
| $193.84 | $249 |
28%
upside
| Overweight |
17 Jun ‘25
2 months ago |
|
11631 |
JM
11631
JP Morgan
Anthony Paolone
|
Camden Property Trust
CPT
$11.8B
| $110.64 | $129 |
17%
upside
| Underweight |
17 Jun ‘25
2 months ago |
|
11632 |
JM
11632
JP Morgan
Bennett Moore
|
Carpenter Technology
CRS
$12.3B
| $247.29 | $305 |
23%
upside
| Overweight |
17 Jun ‘25
2 months ago |
|
11633 |
B
11633
Barclays
George Wang
|
Jabil
JBL
$23B
| $214.73 | $223 |
4%
upside
| Overweight |
17 Jun ‘25
2 months ago |
|
11634 |
DD
11634
DA Davidson
Michael Shlisky
|
Mayville Engineering Co
MEC
$294M
| $14.46 | $23 |
59%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
11635 |
HW&C
11635
HC Wainwright & Co.
Joseph Pantginis
|
Esperion Therapeutics
ESPR
$508M
| $2.52 | $16 |
535%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
11636 |
U
11636
UBS
Ashwani Verma
|
Alkermes
ALKS
$4.43B
| $26.85 | $42 |
56%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
11637 |
C
11637
Citigroup
Geoff Meacham
|
Protagonist Therapeutics
PTGX
$3.58B
| $57.47 | $72 |
25%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
11638 |
C
11638
Citigroup
Geoff Meacham
|
NewAmsterdam Pharma
NAMS
$2.95B
| $26.18 | $42 |
60%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
11639 |
C
11639
Citigroup
Geoff Meacham
|
Arcellx
ACLX
$3.95B
| $71.28 | $110 |
54%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
11640 |
C
11640
Citigroup
Geoff Meacham
|
Amylyx Pharmaceuticals
AMLX
$1.07B
| $11.97 | $12 |
0%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
11641 |
GR
11641
GLJ Research
Gordon Johnson
|
SolarEdge
SEDG
$1.76B
| $29.63 | $6.90 |
77%
downside
| Sell |
17 Jun ‘25
2 months ago |
|
11642 |
C
11642
Citigroup
Geoff Meacham
|
Acumen Pharmaceuticals
ABOS
$84.8M
| $1.40 | $4 |
186%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
11643 |
N
11643
Needham
Laura Martin
|
DoubleVerify
DV
$2.25B
| $13.73 | $18 |
31%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
11644 |
C
11644
Citigroup
Geoff Meacham
|
Novavax
NVAX
$1.29B
| $7.95 | $6 |
25%
downside
| Sell |
17 Jun ‘25
2 months ago |
|
11645 |
HW&C
11645
HC Wainwright & Co.
Joseph Pantginis
|
Galectin Therapeutics
GALT
$317M
| $4.95 | $6 |
21%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
11646 |
LC
11646
Loop Capital
Alan Gould
|
Roku
ROKU
$13.7B
| $93.11 | $100 |
7%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
11647 |
HW&C
11647
HC Wainwright & Co.
Joseph Pantginis
|
BLRX
BioLineRX
BLRX
$16.1M
| $3.78 | $26 |
588%
upside
| Buy |
17 Jun ‘25
2 months ago |
|
11648 |
N
11648
Needham
John Todaro
|
Riot Platforms
RIOT
$5.83B
| $15.78 | $15 |
5%
downside
| Buy |
17 Jun ‘25
2 months ago |
|
11649 |
JM
11649
JP Morgan
Anthony Paolone
|
FVR
FrontView REIT, Inc.
FVR
$275M
| $13.44 | $12 |
11%
downside
| Neutral |
17 Jun ‘25
2 months ago |
|
11650 |
JT
11650
Jones Trading
Debanjana Chatterjee
|
Theravance Biopharma
TBPH
$687M
| $13.65 | $24 |
76%
upside
| Buy |
17 Jun ‘25
2 months ago |
|